Researchers at the University of Texas at Austin have developed a noninvasive, wearable ultrasound patch that helps users reach REM sleep faster and maintain it longer. The NEUSLeeP device, which simultaneously monitors brain activity, shows promise as a potential therapeutic tool for managing chronic insomnia, depression, and PTSD.
Nexalin Technology has secured a US patent for its Deep Intracranial Frequency Stimulation (DIFS) platform, protecting its noninvasive, in-home treatment method for insomnia, anxiety, and depression through 2042. The patent reinforces the company’s strategy to expand physician-supervised, drug-free neurostimulation care via its virtual clinic model.
The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.
How CPAP mask acoustics have improved to facilitate better sleep for the patient and the oft-overlooked bed partner.
The collaboration leverages MellingMedical’s federal contracting network to provide veterans and active-duty personnel with Airway Management's myTAP and myTAP PAP devices, aligning with 2025 VA/DoD guidelines.
New survey data suggest that limited awareness, plus other key factors, constrain the adoption of positional therapies for sleep apnea.
'Sleep issues are a significant challenge for many veterans, and we are proud to offer an effective, drug-free solution that can have a meaningful impact on their health and well-being.'
Treatment for OSA typically starts downstream with the throat, instead of upstream in the nose, the first site of breathing difficulty.
A financing and leadership expansion will accelerate the commercialization of Noctrix’s Nidra tonic motor activation therapy for restless legs syndrome.
Bairitone Health's platform uses passive sleep sonar and a facial patch to map airway anatomy during natural sleep, aiming to pinpoint the root causes of obstruction and guide personalized therapy.
Sleep Review‘s nasal dilators guide compares the devices on parameters such as availability, price, sizes, materials, usage, and supporting studies, as well as advises on how sleep professionals can request samples.
Full data set demonstrates proximal hypoglossal nerve stimulation yields clinically significant and sustained improvements for patients with moderate to severe OSA.
Compare devices on parameters such as form factor, light color, bandwidth, intensity, dimensions, and price.
Spatial Sleep uses facial-scan–based sound and vibration profiles to deliver a customized, nonpharmacologic approach to calming the mind at bedtime.
A Montefiore Einstein study finds that heavy use of deep sedation during mechanical ventilation increases the risk of long-term disability, prompting a shift toward early mobilization and non-opioid, symptom-focused care.